Remedy Routes
    rct
    2023
    High Quality

    A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD

    Kanaan RA, Oliver G, Dharan A

    Published in Psychiatry Research, Vol. 327, pp. 115398

    Key Findings

    Adjunctive NAC provided no benefit over placebo for treatment-resistant PTSD symptom severity.

    Conclusions

    No benefit of NAC was observed beyond placebo.

    Supplements Studied

    No benefit of NAC was observed in this group beyond that provided by placebo at end of the trial.

    Related Health Concerns

    Hypervigilance
    Post-Traumatic Stress Disorder

    Study Details

    Year:2023
    Quality Score:8/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.